drugset / Trial / NCT02170610
Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
To assess the extent of absorption of 150 mg of BIBR 1048 administered as capsule formulation with and without coadministration of 40 mg Pantoprazole and to assess the effect of food on rate and extent of absorption.
Timeline
- Start
- 2002-03
- Primary completion
- 2002-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
| Subject | Pantoprazole | Other / unclassified | 40 mg | — |
Indications
No indication recorded.